🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with...
Status
Terminated
Location
Herlev Hospital
Start Date
2020-10-16
Trial ID
NCT04411082
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
Dysphagia is a disabling, life-threatening symptom that can cause death in ...
Status
Completed
Location
Santa Lucia foundation
Start Date
2022-01-21
Trial ID
NCT05063708
This is a multi-center, long-term safety and efficacy follow-up study for s...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02633943
Treatments Being Tested
The investigate will conduct a cohort study to compare the growth and devel...
Status
Recruiting
Location
Regenerative Medicine Center
Start Date
2023-06-05
Trial ID
NCT05991336
Treatments Being Tested
The purpose of this study is to compare four different connective tissue gr...
Status
Completed
Location
University of Milan
Start Date
2018-08-16
Trial ID
NCT03584906
The primary objective of this study is to compare the effect of mitapivat v...
Status
Recruiting
Location
Weill Cornell Medical College/ New York Presbyterian
Start Date
2026-09
Trial ID
NCT07506863
Treatments Being Tested
The annual frequency of injury among dancers has been reported to range bet...
Status
Completed
Location
Toronto Western Hospital
Start Date
2007-04
Trial ID
NCT00554957
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Active Not Recruiting
Location
University of California San Francisco
Start Date
2022-04-29
Trial ID
NCT05444894
Treatments Being Tested